LUNG CONNECT is an international group of experts in the field of thoracic oncology and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients.
LUNG CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Pierre Fabre Laboratories and Boehringer Ingelheim.
What’s new from LUNG CONNECT
Conference update
ESMO 2024: New data on GI, lung, HCC, breast and GU cancers
Renowned medical experts share their insights into new data presented at ESMO 2024
-
Downloadable
Resources -
MIN
-
Sep 2024
Sep 2024 
Animated Video
BRAF V600E mutated NSCLC: The evolving treatment landscape
Expert insights into personalised treatment strategies in BRAF-mutated NSCLC
Experts
Prof. Amanda TufmanEndorsed by
-
Downloadable
Resources -
6 MIN
-
May 2025
Podcast
Understanding rare non-small cell lung cancer (NSCLC) mutations
Insights and support for patients with a rare alteration of NSCLC
Experts
Dr Joshua Sabari, Debra MontagueEndorsed by
-
Downloadable
Resources -
5 MIN
-
May 2025
Podcast
Episode
2
of 2
The HER2 diagnostic and treatment landscape in NSCLC: Episode 2
Navigating common treatment scenarios in HER2-mutant non-small cell lung cancer
Experts
Dr Eric Singhi, Dr Isabel Preeshagul, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
18 MIN
-
Apr 2025
Publication
Emerging molecular testing paradigms in NSCLC management
Experts
Prof. Frédérique Penault-Llorca, Prof. Mark Socinski-
Downloadable
Resources -
20 MIN
-
Apr 2025
Podcast
Episode
1
of 2
The HER2 diagnostic and treatment landscape in NSCLC: Episode 1
A medical oncologist and a pathologist share their perspectives on best practices in identifying HER2-directed NSCLC
Experts
Prof. Fernando López-Ríos, MD, PhD, Dr Devika Das, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
20 MIN
-
Apr 2025